These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 11809922

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Propionyl-L-carnitine as protector against adriamycin-induced cardiomyopathy.
    Sayed-Ahmed MM, Salman TM, Gaballah HE, Abou El-Naga SA, Nicolai R, Calvani M.
    Pharmacol Res; 2001 Jun; 43(6):513-20. PubMed ID: 11419959
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of L-carnitine supplementation on lipid metabolism of renal failure, dialysis-dependent children and adolescents].
    Böhles H, Michalk D, von Wendt-Göknur E.
    Infusionstherapie; 1991 Oct; 18(5):224-6. PubMed ID: 1769735
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Carnitine promotes heat shock protein synthesis in adriamycin-induced cardiomyopathy in a neonatal rat experimental model.
    Strauss M, Anselmi G, Hermoso T, Tejero F.
    J Mol Cell Cardiol; 1998 Nov; 30(11):2319-25. PubMed ID: 9925368
    [Abstract] [Full Text] [Related]

  • 10. The protection of selenium on adriamycin-induced mitochondrial damage in rat.
    Taskin E, Dursun N.
    Biol Trace Elem Res; 2012 Jun; 147(1-3):165-71. PubMed ID: 22237420
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Protection from adriamycin-induced cardiomyopathy in rats.
    Shug AL.
    Z Kardiol; 1987 Jun; 76 Suppl 5():46-52. PubMed ID: 3433883
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of gene expression of heart fatty acid binding protein and organic cation/carnitine transporter in doxorubicin cardiomyopathic rat model.
    Sayed-Ahmed MM, Al-Shabanah OA, Hafez MM, Aleisa AM, Al-Rejaie SS.
    Eur J Pharmacol; 2010 Aug 25; 640(1-3):143-9. PubMed ID: 20470772
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of l-carnitine on lipid pattern in debilitated patients treated with Intralipid.
    Pola P, Tondi P, Flore R, Serricchio M, Dal Lago A, Amanti C, Consorti F, Benedetti M, Midiri H.
    Int J Clin Pharmacol Res; 1983 Aug 25; 3(3):179-84. PubMed ID: 6592157
    [Abstract] [Full Text] [Related]

  • 17. Melatonin-induced gene expression changes and its preventive effects on adriamycin-induced lipid peroxidation in rat liver.
    Catalá A, Zvara A, Puskás LG, Kitajka K.
    J Pineal Res; 2007 Jan 25; 42(1):43-9. PubMed ID: 17198537
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Differential expression of HSP70 and ultrastructure of heart and liver tissues of rats treated with adriamycin: protective role of L-carnitine.
    Strauss M, Porras N.
    Invest Clin; 2007 Mar 25; 48(1):33-43. PubMed ID: 17432542
    [Abstract] [Full Text] [Related]

  • 20. Protective effect of DL-alpha-lipoic acid on cyclophosphamide induced hyperlipidemic cardiomyopathy.
    Mythili Y, Sudharsan PT, Sudhahar V, Varalakshmi P.
    Eur J Pharmacol; 2006 Aug 14; 543(1-3):92-6. PubMed ID: 16814280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.